209 related articles for article (PubMed ID: 18560225)
1. Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems combined with EDTA against Pseudomonas aeruginosa strains producing VIM-metallo beta-lactamases.
Bedenić B; Vranes J; Sviben M; Beader N; Kalenić S
Chemotherapy; 2008; 54(3):188-93. PubMed ID: 18560225
[TBL] [Abstract][Full Text] [Related]
2. In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.
Ishii Y; Eto M; Mano Y; Tateda K; Yamaguchi K
Antimicrob Agents Chemother; 2010 Sep; 54(9):3625-9. PubMed ID: 20606062
[TBL] [Abstract][Full Text] [Related]
3. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
van der Bij AK; Mol M; van Westreenen M; Goessens WH; Pitout JD
Scand J Infect Dis; 2011 Aug; 43(8):596-602. PubMed ID: 21506891
[TBL] [Abstract][Full Text] [Related]
4. Bulgecin A as a β-lactam enhancer for carbapenem-resistant
Skalweit MJ; Li M
Drug Des Devel Ther; 2016; 10():3013-3020. PubMed ID: 27703329
[TBL] [Abstract][Full Text] [Related]
5. EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase-producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations.
Lasko MJ; Gill CM; Asempa TE; Nicolau DP
BMC Microbiol; 2020 Jul; 20(1):220. PubMed ID: 32690021
[TBL] [Abstract][Full Text] [Related]
6. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the first VIM metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia.
Lepsanovic Z; Libisch B; Tomanovic B; Nonkovici Z; Balogh B; Füzi M
Acta Microbiol Immunol Hung; 2008 Dec; 55(4):447-54. PubMed ID: 19130752
[TBL] [Abstract][Full Text] [Related]
8. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P
Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing
Gill CM; Lasko MJ; Asempa TE; Nicolau DP
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238433
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the mechanism of drug resistance of VIM-2-type metallo-β-lactamase-producing Acineto- bacter baumannii isolated from burn patients and its homology].
Xili Y; Yue L; Jianhua Z; Fei G; Dinghong M; Nianyun W; Guohui L; Guanghua G
Zhonghua Shao Shang Za Zhi; 2015 Jun; 31(3):205-10. PubMed ID: 26564568
[TBL] [Abstract][Full Text] [Related]
11. [Carbapenem resistance determined by metalloenzymes in clinical isolates of Pseudomonas aeruginosa].
Sánchez A; Salso S; Culebras E; Picazo JJ
Rev Esp Quimioter; 2004 Dec; 17(4):336-40. PubMed ID: 15696224
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
13. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
[TBL] [Abstract][Full Text] [Related]
14. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
Walsh F; Bracher S; Turner P; Amyes S
Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
16. Detection of metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients.
Hemalatha V; Sekar U; Kamat V
Indian J Med Res; 2005 Aug; 122(2):148-52. PubMed ID: 16177473
[TBL] [Abstract][Full Text] [Related]
17. Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa.
Migliavacca R; Docquier JD; Mugnaioli C; Amicosante G; Daturi R; Lee K; Rossolini GM; Pagani L
J Clin Microbiol; 2002 Nov; 40(11):4388-90. PubMed ID: 12409438
[TBL] [Abstract][Full Text] [Related]
18. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
[TBL] [Abstract][Full Text] [Related]
19. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
20. Characterization of multidrug-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from a paediatric clinic in China.
Dong F; Xu XW; Song WQ; Lü P; Yu SJ; Yang YH; Shen XZ
Chin Med J (Engl); 2008 Sep; 121(17):1611-6. PubMed ID: 19024085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
